Biotech

All Articles

Cullinan, after $25M deal, restore bispecific to Harbour

.Cullinan Therapeutics was actually thrilled enough with Port BioMed's bispecific immune activator t...

A nearer look at Intense Biotech's Ferocious 15

.Within this week's incident of "The Best Line," our company are actually diving into Strong Biotech...

Lilly deals with stage 2 breakdown of tau-targeting med

.The confetti is actually still flying from Eli Lilly's event commemorating the approval of Alzheime...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of substantial management hirings, shootings and...

Lykos will talk to FDA to reconsider its choice observing turndown of MDMA therapy for trauma

.Adhering to a bad revealing for Lykos Therapies' MDMA applicant for post-traumatic stress disorder ...

AN 2 fifty percents headcount, stops stage 3 trial after information disappoint

.AN2 Rehabs is actually rethinking its own company in feedback to lackluster midphase data, swearing...

Merck spends $700M for bispecific, snooping autoimmune opening and odds to challenge Amgen in cancer cells

.Merck &amp Co. is actually paying $700 thousand in advance to test Amgen in a blood stream cancer m...

Gilead pays J&ampJ $320M to go out licensing package for seladelpar

.With Gilead Sciences about to an FDA decision for its own liver disease medicine seladelpar, the bu...

' All palms on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks can see the providers setting up tents at basecamp behind Eli L...

Entero giving up workers, vacating workplace and also pausing R&ampD

.Mattress Liquidators has turned Entero Therapeutics white as a piece. The financial institution ord...